Skip Navigation



JAC Advance Access published online on February 29, 2008

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkn070
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/5/1076    most recent
dkn070v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rodrigues, L.
Right arrow Articles by Amaral, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodrigues, L.
Right arrow Articles by Amaral, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis

Liliana Rodrigues1,2, Dirk Wagner3, Miguel Viveiros1, Daniela Sampaio1,2, Isabel Couto1,4, Martina Vavra3, Winfried V. Kern3 and Leonard Amaral1,2,*

1 Unit of Mycobacteriology, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Rua da Junqueira 96, 1349-008 Lisboa, Portugal 2 UPMM, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Rua da Junqueira 96, 1349-008 Lisboa, Portugal 3 Center for Infectious Diseases and Travel Medicine, University Hospital, Hugstetter Strasse 55, D-79106 Freiburg, Germany 4 Centro de Recursos Microbiológicos (CREM), Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal

Received 24 October 2007; returned 21 December 2007; revised 13 December 2007; accepted 30 January 2008


* Corresponding author. Tel: +351-21-365-2653; Fax: +351-21-363-2105; E-mail: lamaral{at}ihmt.unl.pt

Objectives: Therapy of AIDS patients infected with Mycobacterium avium is problematic due to its intrinsic resistance to antibiotics. We have characterized the efflux pump activity of M. avium wild-type strain through an automated fluorometric method and correlated it with intrinsic resistance to antibiotics.

Methods: M. avium ATCC 25291T and Mycobacterium smegmatis mc2155 were evaluated for accumulation and efflux of ethidium bromide in the presence or absence of the efflux pump inhibitors (EPIs) thioridazine, chlorpromazine, verapamil and the proton uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP). For this purpose, a new automated fluorometric method was used that separately assesses accumulation and extrusion of ethidium bromide.

Results: The automated fluorometric method described in this paper allowed the detection and quantification of ethidium bromide transport across M. avium and M. smegmatis cell walls. Accumulation of ethidium bromide was found to be temperature-dependent and significantly increased by EPIs thioridazine, chlorpromazine, verapamil and CCCP in a concentration-dependent manner. Efflux of ethidium bromide under optimum conditions of temperature and glucose is inhibited by the above agents. At half their intrinsic MICs, both thioridazine and chlorpromazine, similarly to verapamil and CCCP, significantly increased the susceptibility of M. avium to erythromycin, suggesting an effect upon an efflux pump with ethidium bromide and erythromycin as substrates. A similar effect was observed for M. smegmatis with verapamil only.

Conclusions: M. avium and M. smegmatis intrinsic resistance is affected by EPIs such as thioridazine or chlorpromazine, an effect that might be important in research and development of new, more effective antimycobacterial therapies.

Key Words: mycobacteria , phenothiazines , efflux pumps , efflux pump inhibitors , automated fluorometric method


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Med MicrobiolHome page
N. K. Dutta, K. Mazumdar, A. DasGupta, and S. G. Dastidar
Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice
J. Med. Microbiol., December 1, 2009; 58(12): 1667 - 1668.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. E. Louw, R. M. Warren, N. C. Gey van Pittius, C. R. E. McEvoy, P. D. Van Helden, and T. C. Victor
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3181 - 3189.
[Full Text] [PDF]


Home page
In VivoHome page
G. SPENGLER, A. MARTINS, Z. SCHELZ, L. RODRIGUES, L. AAGAARD, M. MARTINS, S. S. COSTA, I. COUTO, M. VIVEIROS, S. FANNING, et al.
Characterization of Intrinsic Efflux Activity of Enterococcus faecalis ATCC29212 by a Semi-automated Ethidium Bromide Method
In Vivo, January 1, 2009; 23(1): 81 - 87.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.